Stock Information
Attovia Therapeutics Inc (ATTO)
Ticker Symbol: ATTO
Exchange: NASDAQ
Sector: N/A
Market Cap: $665.04 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): N/A
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: N/A%
Latest News
-
Primary Markets Group August IPO Update
Sat, Sep 5, 2026 2:30 AM
-
Quanex Building Products, Concrete Pumping, SanDisk And Other Big Stocks Moving Higher On Friday
Fri, Sep 4, 2026 11:26 AM
-
Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Wed, Sep 2, 2026 8:05 PM
-
Attovia Therapeutics Q2 EPS $(4.88) Misses $(4.62) Estimate, Sales $450.000K
Wed, Sep 2, 2026 4:09 PM
-
Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says
Mon, Aug 31, 2026 3:16 PM
-
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
Mon, Aug 31, 2026 1:45 PM
-
Here Are Monday’s Top Wall Street Analyst Research Calls: AGCO Corporation, Deere & Co., Edison International, Lumentum Holdings, PG&E, Sempra Energy, STAG Industrial, Ticketplus, and More
Mon, Aug 31, 2026 11:56 AM
-
Citigroup Initiates Coverage On Attovia Therapeutics with Buy Rating, Announces Price Target of $30
Mon, Aug 31, 2026 11:06 AM
-
LifeSci Capital Initiates Coverage On Attovia Therapeutics with Outperform Rating, Announces Price Target of $45
Mon, Aug 31, 2026 10:34 AM
-
Leerink Partners Initiates Coverage On Attovia Therapeutics with Outperform Rating, Announces Price Target of $52
Mon, Aug 31, 2026 10:29 AM
Key Financials
Financial data not available
